Form 4: United Therapeutics Director Judy D. Olian Sells 1,700 Shares
SEC Form 4
Director Judy D. Olian sold 1,700 shares of United Therapeutics Corp (UTHR) on June 17, 2024, at a price of $295.4267 per share.
Summary
- On June 17, 2024, Judy D. Olian, a director of United Therapeutics Corporation, sold 1,700 shares of common stock.
- The sale price was $295.4267 per share.
- Following the transaction, Olian directly owns 5,605 shares of United Therapeutics common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC Form 4 filing, indicating a stock sale by a company director. It doesn't inherently convey positive or negative sentiment, but rather reports a transaction.
Industry Context
Form 4 filings are a routine part of insider trading activity and are used by investors to gauge sentiment of company directors and officers.
Stakeholder Impact
- The sale of shares by a director could be perceived negatively by some shareholders, although it is a common occurrence.
Key Dates
| Date | Description |
|---|---|
| 06/17/2024 | Date of transaction: Sale of 1,700 shares of common stock. |
| 06/18/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.